Stocks
Amicus Therapeutics (FOLD) FCF conversion US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| FCF conversion, % | 101.7% | 85.4% | 83.1% | -127.4% | 55.5% | 55.5% | |||
| Changes by years, y/y, % | +4pp | -16pp | -2pp | -211pp | +183pp | +40% | |||
Amicus Therapeutics. FCF conversion, %
Amicus Therapeutics. FCF conversion, changes, pp
Amicus Therapeutics (FOLD) FCF conversion US GAAP (quarter values) |
||||||||
| FY2024Q4 | FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | LTM ? | |||
| FCF conversion, % | -19.2% | -158.8% | 501.9% | 73.7% | 96.9% | 55.5% | ||
| Changes by years, y/y, % | -9pp | -267pp | +356pp | +181pp | +116pp | |||
| Changes by quarters, q/q, % | +89pp | -140pp | +661pp | -428pp | +23pp | |||
